Thomas Moehler

Prognostic Significance of Focal Lesions in Whole-Body Magnetic Resonance Imaging in Patients With Asymptomatic Multiple Myeloma

Jens Hillengaß, Kerstin Fechtner, Marc‐André Weber et al. · Journal of Clinical Oncology · 2010 · 375 citations · Full text

Heparanase influences expression and shedding of syndecan-1, and its expression by the bone marrow environment is a bad prognostic factor in multiple myeloma

Karène Mahtouk, Dirk Hose, P Raynaud et al. · Blood · 2007 · 133 citations · Full text

Synergy between an antiangiogenic integrin α_vantagonist and an antibody–cytokine fusion protein eradicates spontaneous tumor metastases

Holger N. Lode, Thomas Moehler, Rong Xiang et al. · Proceedings of the National Academy of Sciences · 1999 · 127 citations

Immunology, Immunoediting, Pathology +19

Salvage therapy for multiple myeloma with thalidomide and CED chemotherapy

Thomas Moehler, Kai Neben, Axel Benner et al. · Blood · 2001 · 124 citations · Full text

Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance: Importance of Whole-Body versus Spinal MR Imaging

Tobias Bäuerle, Jens Hillengaß, Kerstin Fechtner et al. · Radiology · 2009 · 123 citations